Literature DB >> 22282659

Ribosome biogenesis and control of cell proliferation: p53 is not alone.

Giulio Donati1, Lorenzo Montanaro, Massimo Derenzini.   

Abstract

Cell growth is a prerequisite for cell proliferation, and ribosome biogenesis is a limiting factor for cell growth. In mammalian cells, the tumor suppressor p53 has been shown to induce cell-cycle arrest in response to impaired ribosome biogenesis. Recently, p53-independent mechanisms of cell-cycle arrest in response to alterations of ribosome biogenesis have been described. These findings provide a rational basis for the use of drugs that specifically impact ribosome biogenesis for the treatment of cancers lacking active p53 and extend the scenario of mechanisms involved in the relationship between cell growth and cell proliferation. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282659     DOI: 10.1158/0008-5472.CAN-11-3992

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  72 in total

1.  p53 is positively regulated by miR-542-3p.

Authors:  Yemin Wang; Jen-Wei Huang; Maria Castella; David George Huntsman; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

2.  Changes to cellular water and element content induced by nucleolar stress: investigation by a cryo-correlative nano-imaging approach.

Authors:  Frédérique Nolin; Jean Michel; Laurence Wortham; Pavel Tchelidze; Gérard Balossier; Vincent Banchet; Hélène Bobichon; Nathalie Lalun; Christine Terryn; Dominique Ploton
Journal:  Cell Mol Life Sci       Date:  2013-02-06       Impact factor: 9.261

Review 3.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

4.  Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.

Authors:  M Monika Belickova; Michaela Dostalova Merkerova; Hana Votavova; Jan Valka; Jitka Vesela; Barbora Pejsova; Hana Hajkova; Jiri Klema; Jaroslav Cermak; Anna Jonasova
Journal:  Int J Hematol       Date:  2016-07-14       Impact factor: 2.490

Review 5.  Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.

Authors:  X Xie; P Guo; H Yu; Y Wang; G Chen
Journal:  Oncogene       Date:  2017-09-25       Impact factor: 9.867

6.  Conditional depletion of the RNA polymerase I subunit PAF53 reveals that it is essential for mitosis and enables identification of functional domains.

Authors:  Rachel McNamar; Zakaria Abu-Adas; Katrina Rothblum; Bruce A Knutson; Lawrence I Rothblum
Journal:  J Biol Chem       Date:  2019-11-14       Impact factor: 5.157

7.  SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.

Authors:  Nicolas M Bertagnolli; Justin A Drake; Jason M Tennessen; Orly Alter
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

8.  Growth inhibitory effects of large subunit ribosomal proteins in melanoma.

Authors:  Gregory R Kardos; Mu-Shui Dai; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2014-06-16       Impact factor: 4.693

9.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

10.  Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner.

Authors:  Annapina Russo; Davide Esposito; Morena Catillo; Concetta Pietropaolo; Elvira Crescenzi; Giulia Russo
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.